Register Login
Register to leave comments
  • News bot Aug. 3, 2026, 8:54 p.m.

    📋 JASPER THERAPEUTICS, INC. (JSPRW) - Regulatory Update

    Filing Date: 2026-08-03

    Accepted: 2026-08-03 16:47:55

    Event Type: Regulatory Update

    Event Details:

    JASPER THERAPEUTICS, INC. (JSPRW) Announces Regulatory Update JASPER THERAPEUTICS, INC. (JSPRW) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (JASPER THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Cognitive Behavioral Therapy Drug Phase EARLY_PHASE1 Social Anxiety Disorder ClinicalTrials.gov
    Placebo Other Phase EARLY_PHASE1 Social Anxiety Disorder ClinicalTrials.gov
    D-Cycloserine Other Phase EARLY_PHASE1 Social Anxiety Disorder ClinicalTrials.gov
    SHAM Training Other Approved Tobacco Use ClinicalTrials.gov
    Approach Avoidance Training Other Approved Tobacco Use ClinicalTrials.gov
    Approach Bias Retraining Other Approved Nicotine Dependence ClinicalTrials.gov
    Community Engagement Other Approved Reintegration ClinicalTrials.gov
    Vigorous Intensity Aerobic Exercise and Community Engagement Other Approved Reintegration ClinicalTrials.gov
    Smoking Cessation Intervention Other Approved Nicotine Dependence ClinicalTrials.gov
    Aerobic exercise Other Approved Nicotine Dependence ClinicalTrials.gov
    Cue Exposure Other Phase EARLY_PHASE1 Nicotine Dependence ClinicalTrials.gov
    Isradipine Other Phase EARLY_PHASE1 Nicotine Dependence ClinicalTrials.gov
    Yoga Other Approved Yoga ClinicalTrials.gov
    Deprexis Other Approved MDD ClinicalTrials.gov
    Exposure-Based Therapy Drug Approved Obsessive-Compulsive Disorder ClinicalTrials.gov
    Nicotine patch Other Phase PHASE3 Nicotine Dependence ClinicalTrials.gov
    Counseling Other Phase PHASE3 Nicotine Dependence ClinicalTrials.gov
    Nelfinavir and Omeprazole Other Phase PHASE4 Healthy Volunteers ClinicalTrials.gov
    Humanized anti-CD117 Monoclonal Antibody (JSP191) Other Phase PHASE1 MYELODYSPLASTIC SYNDROME; MDS ClinicalTrials.gov
    Clinician and Non-clinician staff training Other Approved LGBT Health ClinicalTrials.gov
    Tumor resection Other Preclinical Glioblastoma ClinicalTrials.gov
    Tumor biopsy Other Preclinical Glioblastoma ClinicalTrials.gov
    Palliative Care Other Preclinical Glioblastoma ClinicalTrials.gov
    Maximal safe resection Other Preclinical Glioblastoma ClinicalTrials.gov
    Supramaximal resection Other Preclinical Glioblastoma ClinicalTrials.gov
    JSP191 Other Phase PHASE1 Lower-risk Myelodysplastic Syndrome ClinicalTrials.gov
    Placebo Comparator Other Phase PHASE1 Allergic Asthma ClinicalTrials.gov
    Briquilimab Other Phase PHASE1 Allergic Asthma ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: JASPER THERAPEUTICS, INC.
    • Ticker Symbol: JSPRW

Search

News categories